PANCE Blueprint Pulmonary (9%)

HIV-related pneumonia

Patient will present as → a 32-year-old male with dyspnea and a nonproductive cough. He is tachycardic, tachypneic and febrile. Auscultation of his chest reveals scattered rhonchi. His chest x-ray demonstrates a diffuse interstitial infiltrate. His ABG demonstrates moderate hypoxemia, and his LDH is elevated.

Formerly PCP Pneumonia, now called (PJP) Pneumocystis jiroveci (there are other HIV-related pneumonias, but this is the one you will need to know for the test)

  • Common in HIV-infected patients with a low CD4 count of less than 200

CXR is the cornerstone of diagnosis. The radiograph shows diffuse interstitial or bilateral perihilar infiltrates

  • Diagnose with bronchoalveolar lavage (BAL) (GOLD STANDARD) (by PCR), labs, and an HIV test
  • Methenamine silver stain is used to stain Pneumocystis. Samples of affected tissue, such as lung tissue from a biopsy, can be stained to reveal the pathogen
  • Will often have very low O2 saturation despite supplemental O2

Treat with Trimethoprim-sulfamethoxazole (BACTRIM) and steroids if PaO₂ <70 mmHg on room air

  • If allergic or intolerant to TMP-SMX (severity-based alternatives)
    • Moderate-to-Severe Disease: Primaquine + Clindamycin (Preferred over IV Pentamidine due to better safety profile)
    • Mild-to-Moderate Disease: Atovaquone or Dapsone + Trimethoprim

Prophylaxis for high-risk patients with a CD4 count <200 cells/µL or with a history of prior PJP infection

  • Daily Bactrim is the prophylaxis antibiotic of choice
X-ray of ground glass opacities of pneumocystis pneumonia

These chest radiographs are of two patients. Both show a ground-glass appearance. The left chest X-ray (CXR) shows a much more subtle ground-glass appearance, while the right CXR shows a much more gross ground-glass appearance mimicking pulmonary edema.

Picmonic
Pneumocystis jiroveci

_IM_Pneumocystis-Jiroveci_v1.5_

Pneumocystis jiroveci is a fungal infection which typically presents with hypoxia and fever in the lungs of immunocompromised patients. The infection is usually diagnosed using classic x-ray findings of diffuse interstitial infiltration bilaterally. Definitive diagnosis can be made using lavage or biopsy, were it can be identified by methenamine on silver stain. In order to prevent the disease in patients with HIV and CD4 counts below 200, TMP-SMX is used prophylactically. TMP-SMX is also used as treatment for diagnosed disease.

Play Video + Quiz

Question 1
A 47-year-old HIV positive female presents with a complaint of nonproductive cough. She is febrile, tachypneic, and tachycardic. Lung exam reveals bilateral rales. Chest x-ray shows diffuse interstitial infiltrates. What is the recommended treatment for this patient?
A
Trimethoprim-Sulfamethoxazole (Bactrim)
B
Tetracycline (Sumycin)
Hint:
Tetracycline, amantadine, and ticarcillin are not effective against PCP.
C
Amantadine (Symmetrel)
Hint:
Tetracycline, amantadine, and ticarcillin are not effective against PCP.
D
Ticarcillin (Ticar)
Hint:
Tetracycline, amantadine, and ticarcillin are not effective against PCP.
Question 1 Explanation: 
TMP-SMX is the drug of choice for all forms of pneumocystis. Prophylaxis is provided for high-risk patients with a CD4 count of less than 200 or with a history of PJP infection. Daily Bactrim is the prophylaxis antibiotic of choice.
Question 2
A 34-year-old man with untreated HIV infection (CD4 count 90 cells/µL) presents with 3 weeks of progressively worsening exertional dyspnea and a nonproductive cough. Temperature is 38.2°C (100.8°F), respiratory rate is 26/min, and oxygen saturation is 89% on room air. Chest radiograph shows diffuse bilateral interstitial infiltrates, and serum lactate dehydrogenase is markedly elevated. Which of the following is the most appropriate test to confirm the diagnosis?
A
Blood cultures
B
Bronchoalveolar lavage with methenamine silver staining
C
CT pulmonary angiography
D
Nasopharyngeal viral PCR
E
Sputum acid-fast bacilli smear
Question 2 Explanation: 
This presentation is classic for Pneumocystis jirovecii pneumonia (PCP). P. jirovecii cannot be cultured, so diagnosis requires identification of the organism from induced sputum or bronchoalveolar lavage using stains such as methenamine silver, Giemsa, or direct fluorescent antibody, or by PCR. Elevated LDH and diffuse bilateral interstitial (ground-glass) infiltrates in a patient with CD4 <200 support the diagnosis.
Question 3
A 29-year-old woman with newly diagnosed HIV infection is establishing care. She feels well and has no respiratory symptoms. Her CD4 count is 150 cells/µL. In addition to initiating antiretroviral therapy, which of the following is the most appropriate intervention to prevent Pneumocystis pneumonia?
A
Azithromycin
B
Fluconazole
C
Isoniazid
D
Trimethoprim-sulfamethoxazole
E
Valganciclovir
Question 3 Explanation: 
Primary prophylaxis against Pneumocystis jirovecii pneumonia with trimethoprim-sulfamethoxazole is indicated when the CD4 count is <200 cells/µL (or CD4 <14%, or a history of oropharyngeal candidiasis). It can be discontinued once the CD4 count rises to ≥200 cells/µL for ≥3 months on antiretroviral therapy. Azithromycin is used for MAC prophylaxis (CD4 <50), fluconazole for fungal prophylaxis, isoniazid for latent tuberculosis, and valganciclovir is not used for routine PCP prevention.
There are 3 questions to complete.
List
Return
Shaded items are complete.
123
Return

References: Merck Manual · UpToDate

Fungal pneumonia (Prev Lesson)
(Next Lesson) Viral pneumonia
Back to PANCE Blueprint Pulmonary (9%)

NCCPA™ CONTENT BLUEPRINT

Have you tried the NEW Smarty PANCE QBANK? It's FREE with EVERY membership purchase 😀!

X